Application of combination of gambogic acid and sorafenib in preparation of liver cancer treatment medicine
A technology for treating drugs and gambogic acid, applied in the field of biomedicine, can solve the problems of prolonging the survival period and improving the quality of life of patients, lack of first-line treatment plans and drugs, and high heterogeneity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] The growth inhibitory effect of gambogic acid (GA) combined with sorafenib in HepG2 cells 48H was determined by MTT assay
[0022] MTT solution can be reduced to blue-violet crystalline formazan by mitochondrial dehydrogenase in living cells, DMSO can dissolve formazan, and the color of the formed solution is proportional to cell viability, and cell viability can be detected accordingly. The cells were cultured in a 96-well microtiter plate according to the appropriate cell density. The volume of cells in each well was 100 μl. When the cells adhered and the confluence reached 50%, the medium was aspirated and 100 μl of GA and Sora were added at the specified concentrations. Finni; after the cells that had been administered the drug were placed in the incubator for 48 hours, 20 μl of MTT solution was added to each well; after 4 hours of incubation, the supernatant was removed, and 100 μl of DMSO was added to each well, and placed on a micro-shaker to shake until crystalli...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com